PreComb
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.
PreComb has raised €2.0M across 2 funding rounds from 3 investors, most recently a Series A round in Dec 2024. Based in Hombrechtikon, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Hombrechtikon, Switzerlandwww.precomb.com ↗
Total raised
€2.0M
€1,993,115
Funding rounds
2
Investors
3
distinct backers
Active since
2021-04
latest 2024-12
Funding by year
EUR raised per yearPreComb — funding by year — interactive chart.
Data table
| PreComb — funding by year | |
|---|---|
| 2021 | €2.0M |
| 2024 | €0 |
Signals
Medium confidenceRaise-next likelihood63
base rate 44% for Series A
- ▲ In typical raise window
Exit likelihood6
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-30 | Series A | — | — | View deal → |
| 2021-04-27 | Seed | €2.0M | FiveT Capital,High-Tech Gründerfonds (HTGF),Kinled Austria | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData